User profiles for Dejan Micic
 | Dejan MicicUniversity of Chicago Medical Center Verified email at uchicago.edu Cited by 3398 |
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Objectives The prevalence and clinical outcomes of COVID-19 in patients with autoimmune
diseases who are frequently treated with disease modifying therapies remains poorly …
diseases who are frequently treated with disease modifying therapies remains poorly …
Clostridium difficile Ribotype Does Not Predict Severe Infection
Background. Studies of Clostridium difficile outbreaks suggested that certain ribotypes (eg,
027 and 078) cause more severe disease than other ribotypes. A growing number of studies …
027 and 078) cause more severe disease than other ribotypes. A growing number of studies …
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis
A Yamada, Y Komaki, F Komaki, D Micic… - The Lancet …, 2018 - thelancet.com
Background The management and life expectancy of patients with cystic fibrosis have
improved substantially in the past three decades, which has resulted in an increased number of …
improved substantially in the past three decades, which has resulted in an increased number of …
Clostridium difficile Ribotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality
Background. Clostridium difficile infection (CDI) can cause severe disease and death,
especially in older adults. A better understanding of risk factors for adverse outcomes is needed. …
especially in older adults. A better understanding of risk factors for adverse outcomes is needed. …
Predicting outcomes to optimize disease management in inflammatory bowel diseases
…, KH Katsanos, T Lobatón, D Micic… - Journal of Crohn's …, 2016 - academic.oup.com
Background and Aims: Efforts to slow or prevent the progressive course of inflammatory bowel
diseases [IBD] include early and intensive monitoring and treatment of patients at higher …
diseases [IBD] include early and intensive monitoring and treatment of patients at higher …
Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta …
A Sakuraba, A Luna, D Micic - Gastroenterology, 2022 - Elsevier
Background & Aims Patients with immune-mediated inflammatory diseases (IMIDs) have an
increased risk of coronavirus disease 2019 (COVID-19), primarily attributed to the use of …
increased risk of coronavirus disease 2019 (COVID-19), primarily attributed to the use of …
[HTML][HTML] A systematic review and meta-analysis of serologic response following coronavirus disease 2019 (COVID-19) vaccination in solid organ transplant recipients
A Sakuraba, A Luna, D Micic - Viruses, 2022 - mdpi.com
Solid organ transplant (SOT) recipients are at greater risk of coronavirus disease 2019 (COVID-19)
and have attenuated response to vaccinations. In the present meta-analysis, we …
and have attenuated response to vaccinations. In the present meta-analysis, we …
Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta …
F Komaki, Y Komaki, D Micic, A Ido, A Sakuraba - Journal of autoimmunity, 2017 - Elsevier
Background Immune mediated diseases such as rheumatoid arthritis (RA), ankylosing
spondylitis (AS), and inflammatory bowel disease (IBD) commonly affect young and adolescent …
spondylitis (AS), and inflammatory bowel disease (IBD) commonly affect young and adolescent …
Safety and efficacy of combination treatment with calcineurin inhibitors and vedolizumab in patients with refractory inflammatory bowel disease
Background & Aims Little is known about the efficacy and safety of induction therapy with
calcineurin inhibitors in combination with vedolizumab for patients with Crohn's disease (CD) …
calcineurin inhibitors in combination with vedolizumab for patients with Crohn's disease (CD) …
[HTML][HTML] Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
A Sakuraba, A Luna, D Micic - Journal of Hematology & Oncology, 2022 - Springer
Purpose Patients with cancer have an increased risk of coronavirus disease 2019 (COVID-19)
and an attenuated responses to various vaccines. This meta-analysis aims to assess the …
and an attenuated responses to various vaccines. This meta-analysis aims to assess the …
